Related Experiment Videos
Hypoxia as a target for combined modality treatments
B G Wouters1, S A Weppler, M Koritzinsky
1Department of Experimental Radiation Oncology, UNS 50/ Box 23, azM/University of Maastricht, Postbox 616, 6200 MD Maastricht, The Netherlands.
European Journal of Cancer (Oxford, England : 1990)
|January 23, 2002
Summary
Tumor hypoxia, a lack of oxygen in solid tumors, worsens patient prognosis and limits cancer treatments. Exploiting this unique tumor microenvironment offers novel therapeutic strategies for improved cancer care.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Solid tumors exhibit a unique microenvironment characterized by abnormal vasculature, leading to insufficient oxygen and nutrient supply.
- This tumor microenvironment, particularly tumor hypoxia (low oxygen levels), significantly limits the effectiveness of conventional radiotherapy and chemotherapy.
- Tumor hypoxia is an independent prognostic indicator of poor outcomes in various cancers, including prostate, head and neck, and cervical cancers.
Purpose of the Study:
- To review the properties of tumor hypoxia and the tumor microenvironment.
- To discuss current therapeutic strategies that exploit the unique characteristics of the tumor microenvironment for cancer treatment.
- To explore novel approaches for improving cancer therapy by targeting tumor-specific conditions.
Main Methods:
- Review of existing laboratory and clinical data on tumor hypoxia and its effects.
- Categorization of current therapeutic efforts targeting the tumor microenvironment into three main groups.
- Analysis of agents exploiting environmental changes, tumor vasculature, and cellular responses to hypoxia.
Main Results:
- Tumor hypoxia is associated with a more malignant phenotype, impacting genomic stability, apoptosis, angiogenesis, and metastasis.
- Therapeutic strategies are being developed to exploit tumor hypoxia, including bioreductive drugs and hypoxia-specific gene delivery.
- Other strategies target tumor vasculature (angiogenesis inhibitors, vascular targeting agents) and molecular responses to hypoxia.
Conclusions:
- The unique properties of the tumor microenvironment, especially hypoxia, present opportunities for developing novel, tumor-specific therapies.
- Targeting tumor hypoxia and related pathways holds significant promise for improving the efficacy of cancer treatment.
- Further research into exploiting the tumor microenvironment is crucial for advancing cancer care and patient outcomes.